SCHEMBL29940558

SCHEMBL29940558

COC(=O)c1ccc2ncc(C3CC3)cc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.55
ALOX15 P16050 1/20 0.55
PSMB5 P28074 1/20 0.47
PDGFRB P09619 1/20 0.47
PDGFRA P16234 1/20 0.47
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
HSP90AA1 P07900 1/20 0.45
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 4/20 0.42
MAPK1 P28482 2/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PIK3CG P48736 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19780100 1.00 HTT (0.55) HTTALOX15PSMB5PDGFRBPDGFRA
SCHEMBL29277914 0.93 HTT (0.48) HTTALOX15PSMB5PDGFRBPDGFRA
SCHEMBL29940332 0.89 ALOX15 (0.48) HTTALOX15PSMB5PDGFRBPDGFRA
SCHEMBL21355246 0.86 NPC1 (0.51) HTTPSMB5PDGFRBPDGFRANPC1
SCHEMBL29278003 0.83 ALOX15 (0.39) HTTALOX15PSMB5PDGFRBPDGFRA
SCHEMBL29277941 0.83 RXFP1 (0.44) HTTALOX15PSMB5MAPK1NR1H4
SCHEMBL10466162 0.82 HTT (0.67) HTTALOX15NPC1RAB9AALDH1A1
SCHEMBL18369672 0.82 KLKB1 (0.51)
SCHEMBL1644304 0.80 MAPK1 (0.41) HTTALOX15PDGFRBPDGFRAALDH1A1
SCHEMBL264087 0.80 PTPN11 (0.51) HTTALOX15NPC1RAB9AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308229-A1 INHIBITORS OF PLASMA KALLIKREIN Takeda Pharmaceutical Company Limited (JP) 2024-01-24 EP disclosed
WO-2022197763-A1 INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 WO disclosed